NCT06967233View on ClinicalTrials.gov

Multimodal Managements for Metastatic Pancreatic Cancer.

CompletedOBSERVATIONAL
Enrollment

360

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

December 31, 2023

Study Completion Date

April 1, 2025

Conditions
Metastatic Pancreatic Cancer
Interventions
OTHER

Multimodal treatment

Surgical resection, locoregional liver-directed treatments and continuous systemic treatment in patients with liver metastatic pancreatic cancer

Trial Locations (1)

310000

The first affiliated hospital, Zhejiang university school of medicine, Hangzhou

All Listed Sponsors
lead

Zhejiang University

OTHER

NCT06967233 - Multimodal Managements for Metastatic Pancreatic Cancer. | Biotech Hunter | Biotech Hunter